Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet

NCT03437785 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastritis

Interventions

DRUG: CKD-495 75mg
DRUG: CKD-495 150mg
DRUG: Artemisiae argyi folium 95% ethanol ext.(20→1) 60mg
DRUG: Rebamipide 100mg
DRUG: Placebo of the CKD-495 75mg
DRUG: Placebo of the CKD-495 150mg
DRUG: Placebo of Artemisia Herb 95% Ethanol Soft Ext.(20→1) 60mg
DRUG: Placebo of the Rebamipide 100mg

Sponsor

Chong Kun Dang Pharmaceutical